Association of Very Early Treatment Initiation With the Risk of Long-Term Disability in Patients With a First Demyelinating Event.
Álvaro Cobo-CalvoCarmen TurSusana Otero-RomeroPere Carbonell-MirabentMariano RuizAgustín PappollaJavier Villacieros AlvarezÁngela Vidal-JordanaGeorgina ArrambideJoaquín CastillóIngrid GalanMarta Rodríguez BarrancoLuciana Soledad MidagliaCarlos NosBreogan Rodriguez AcevedoAnna ZabalzaNeus MongayJordi RíoManuel ComabellaCristina AugerJaume Sastre-GarrigaAlex RoviraMar TintoreXavier MontalbanPublished in: Neurology (2023)
This study provides Class III evidence that earlier treatment of MS patients presenting with a first demyelinating event is associated with improved clinical outcomes.
Keyphrases